327:(it doesn't seem like you knew this), and the reliability of that source is hard to judge. It does cite one source that mentions Zwanziger explicitly (Inc. Magazine, Dec. 1990, p. 74), and I looked at what it has to say about Zwanziger himself: "Zwanziger grew up in Cyprus, then was educated in Great Britain. He received an engineering degree from Imperial College at London University before attending Harvard Business School." That's it. Standard stuff, no in-depth discussion, nothing. In other words, nothing proves that this person should be notable independently of the company. 12:39, 4 June 2020 (UTC)
403:. I added additional content on the importance of Medisense and LumiraDx (Zwanziger's other ventures, which are not covered by articles). See what you think. Also, if you are still worried about the sourcing after that, it would be helpful if you could suggest what more would be needed. As a brief inventory, we currently have 2 full length profile/biographical pieces in the Harvard case study and the Boston Business Journal article, 2 shorter ones in the Isenberg book and the IDCH article, as well as citations to various newspaper articles which foreground Zwanziger (eg sources 12, 10, 11), etc.
273:
the traditional gold standard of business case studies, and contains several pages of career profile and biographical information on
Zwanziger. The Funding Universe article is actually impeccably researched. These are just the sources you've mentioned, but the article is rather well-sourced, so I could go on. As to whether Zwanziger's notability depends on Alere, the company Medisense which Zwanziger also cofounded is important in the history of
272:
Hi, Zwanziger is a prominent member of the Boston, USA business community. It's not a "mention" in the Boston
Business Joural, but a lengthy profile article under the title "Boston's Barbarian". The "Inverness Medical Innovations--Born Global" source is a Harvard Business School case study, which is
360:
The "Funding
Universe" source was not added by me, and yes it should be corrected to point to the International Directory of Company Histories directly, which is the source of the impeccable research. That source includes 3 full paragraphs on Zwanziger and his earlier company Medisense. As far as I
322:
Hmm. You got one article in a secondary source. You have a "business case study" but it has no proper bibliographic citation, and no link to an online version that editors can judge--that this meets some "gold standard" is your own claim. And you have something from "Funding
Universe" which you say
569:
we currently have 2 full length profile/biographical pieces in the
Harvard case study and the Boston Business Journal article, 2 shorter ones in the Isenberg book and the IDCH article, as well as citations to various newspaper articles which foreground Zwanziger (eg sources 12, 10, 11), etc.
288:
To anyone else joining the conversation, important context: Drmies targeted this article for a redirect only after they became irate about an edit I made and found the article in my contributions history. They then redirected the article without notification or discussion. They are only now
364:
And of course there are other sources on the article that you are ignoring, the book "Worthless, Impossible and Stupid: How
Contrarian Entrepreneurs Create and Capture Extraordinary Value", multiple newspaper articles which address Zwanziger directly.
257:, has an article, and this would be a good target for a redirect. He's mentioned in that one Business Journal, and there's a bunch of mentions on some business-related websites, but in the end his notability depends completely on Alere.
574:
I think those already should establish notability. The main additional sources I've put in are an electrochemistry textbook (Bond 2002), an article in the journal
Chemical Reviews, and a recent Long Island Press article.
222:
281:. Medisense is discussed rather extensively in the article RSes. Additionally Zwanziger is the current CEO of LumiraDx, which apparently raised the 9th largest VC investment in the world for April 2020 (see
504:
289:
proceeding via a proper channel after I expended considerable effort figuring out how to reverse what they did (which, I think it is fair to say, would meet the definition of page vandalism).
451:
216:
175:
537:
Can someone please review the additional sources added. Creator, it would help enormously if you linked the sources establsihing notably in this discussion.
122:
107:
491:
182:
67:
148:
143:
152:
72:
102:
95:
17:
135:
237:
204:
388:. The company is notable. Him, not so much, at least not on the quality of the sources that are there at the moment.
512:
116:
112:
526:
473:
421:
354:
601:
40:
487:
198:
62:
350:
546:
459:
584:
551:
516:
508:
495:
463:
442:
412:
392:
374:
317:
298:
266:
194:
77:
597:
346:
282:
36:
389:
357:. But last time I checked, paywalled academic research is an entirely legitimate source on wikipedia.
244:
576:
404:
366:
309:
290:
580:
483:
408:
370:
313:
294:
278:
230:
57:
558:
541:
455:
139:
91:
29:
The following discussion is an archived debate of the proposed deletion of the article below.
596:
Subsequent comments should be made on the appropriate discussion page (such as the article's
35:
Subsequent comments should be made on the appropriate discussion page (such as the article's
332:
262:
210:
562:
400:
53:
433:
274:
131:
83:
323:
is "impeccably researched"--but
Funding Universe merely reprints material from the
169:
342:
328:
258:
361:
can tell, every claim in the IDCH article is corroborated by its bibliography.
283:
https://pitchbook.com/blog/the-most-funded-vc-companies-in-april-2020
385:
254:
592:
The above discussion is preserved as an archive of the debate.
529:
to generate a more thorough discussion and clearer consensus.
505:
list of United States of
America-related deletion discussions
476:
to generate a more thorough discussion and clearer consensus.
424:
to generate a more thorough discussion and clearer consensus.
561:
There is a partial inventory of sources in my comment to
353:. Unfortunately, to see the publication you will need to
351:
Introduction to the importance of their case study method
165:
161:
157:
229:
540:Please add new comments below this notice. Thanks,
482:Please add new comments below this notice. Thanks,
452:
430:Please add new comments below this notice. Thanks,
43:). No further edits should be made to this page.
604:). No further edits should be made to this page.
503:Note: This discussion has been included in the
450:Note: This discussion has been included in the
243:
8:
347:one of the top business schools in the world
325:International Directory of Company Histories
123:Help, my article got nominated for deletion!
277:and was the basis for the diabetes unit of
502:
449:
355:shell out $ 9 or use institutional access
7:
345:Regarding HBS case studies, HBS is
24:
253:Non-notable person. The company,
108:Introduction to deletion process
18:Knowledge:Articles for deletion
1:
98:(AfD)? Read these primers!
621:
585:07:55, 27 June 2020 (UTC)
565:, which I reproduce here:
552:16:14, 26 June 2020 (UTC)
517:16:49, 24 June 2020 (UTC)
496:23:13, 18 June 2020 (UTC)
464:10:01, 12 June 2020 (UTC)
443:20:28, 11 June 2020 (UTC)
594:Please do not modify it.
413:21:03, 4 June 2020 (UTC)
393:19:30, 4 June 2020 (UTC)
375:18:30, 4 June 2020 (UTC)
318:04:14, 4 June 2020 (UTC)
299:03:48, 4 June 2020 (UTC)
267:03:35, 4 June 2020 (UTC)
78:22:35, 3 July 2020 (UTC)
32:Please do not modify it.
96:Articles for deletion
279:Abbott Laboratories
535:Relisting comment:
554:
519:
509:1234qwer1234qwer4
498:
466:
445:
441:
390:Black Kite (talk)
113:Guide to deletion
103:How to contribute
612:
539:
532:
530:
481:
479:
477:
440:
438:
431:
429:
427:
425:
248:
247:
233:
185:
173:
155:
93:
34:
620:
619:
615:
614:
613:
611:
610:
609:
608:
602:deletion review
555:
525:
523:
499:
472:
470:
446:
434:
432:
420:
418:
190:
181:
146:
130:
127:
90:
87:
48:The result was
41:deletion review
30:
22:
21:
20:
12:
11:
5:
618:
616:
607:
606:
588:
587:
567:
566:
538:
533:
522:
521:
520:
484:RandomCanadian
480:
469:
468:
467:
428:
417:
416:
415:
396:
395:
378:
377:
362:
358:
339:
338:
337:
336:
302:
301:
286:
275:glucose meters
251:
250:
187:
126:
125:
120:
110:
105:
88:
86:
81:
46:
45:
25:
23:
15:
14:
13:
10:
9:
6:
4:
3:
2:
617:
605:
603:
599:
595:
590:
589:
586:
582:
578:
573:
572:
571:
564:
560:
559:Spinningspark
557:
556:
553:
550:
549:
545:
544:
536:
531:
528:
518:
514:
510:
506:
501:
500:
497:
493:
489:
485:
478:
475:
465:
461:
457:
456:Coolabahapple
453:
448:
447:
444:
439:
437:
426:
423:
414:
410:
406:
402:
398:
397:
394:
391:
387:
383:
380:
379:
376:
372:
368:
363:
359:
356:
352:
348:
344:
341:
340:
334:
330:
326:
321:
320:
319:
315:
311:
308:
304:
303:
300:
296:
292:
287:
284:
280:
276:
271:
270:
269:
268:
264:
260:
256:
246:
242:
239:
236:
232:
228:
224:
221:
218:
215:
212:
209:
206:
203:
200:
196:
193:
192:Find sources:
188:
184:
180:
177:
171:
167:
163:
159:
154:
150:
145:
141:
137:
133:
132:Ron Zwanziger
129:
128:
124:
121:
118:
114:
111:
109:
106:
104:
101:
100:
99:
97:
92:
85:
84:Ron Zwanziger
82:
80:
79:
76:
75:
71:
70:
66:
65:
61:
60:
55:
51:
44:
42:
38:
33:
27:
26:
19:
593:
591:
568:
547:
542:
534:
524:
471:
435:
419:
381:
324:
306:
252:
240:
234:
226:
219:
213:
207:
201:
191:
178:
89:
73:
68:
63:
58:
50:no consensus
49:
47:
31:
28:
307:oppose/keep
217:free images
563:Black Kite
436:Sandstein
401:Black Kite
598:talk page
577:Zekelayla
405:Zekelayla
367:Zekelayla
310:Zekelayla
291:Zekelayla
59:King of ♥
37:talk page
600:or in a
543:Spinning
527:Relisted
492:contribs
474:Relisted
422:Relisted
382:Redirect
176:View log
117:glossary
54:WP:NPASR
39:or in a
223:WP refs
211:scholar
149:protect
144:history
94:New to
343:Drmies
329:Drmies
259:Drmies
195:Google
153:delete
548:Spark
386:Alere
255:Alere
238:JSTOR
199:books
183:Stats
170:views
162:watch
158:links
16:<
581:talk
513:talk
488:talk
460:talk
409:talk
399:Hi,
371:talk
333:talk
314:talk
305:So,
295:talk
263:talk
231:FENS
205:news
166:logs
140:talk
136:edit
494:)
384:to
245:TWL
174:– (
56:).
583:)
515:)
507:.
490:/
462:)
454:.
411:)
373:)
349:.
316:)
297:)
285:).
265:)
225:)
168:|
164:|
160:|
156:|
151:|
147:|
142:|
138:|
579:(
511:(
486:(
458:(
407:(
369:(
335:)
331:(
312:(
293:(
261:(
249:)
241:·
235:·
227:·
220:·
214:·
208:·
202:·
197:(
189:(
186:)
179:·
172:)
134:(
119:)
115:(
74:♠
69:♣
64:♦
52:(
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.